AmerisourceBergen Announces Date and Time for Earnings Release
VALLEY FORGE, Pa.--(BUSINESS WIRE)--Sept. 21, 2004--AmerisourceBergen Corporation (NYSE:ABC) today announced that it plans to release its Fourth Quarter and Year End results for Fiscal Year 2004 on Tuesday, November 2, 2004 prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 11:00 am Eastern Standard Time on November 2, 2004.
Participating in the conference call will be: R. David Yost, Chief Executive Officer Kurt J. Hilzinger, President & Chief Operating Officer Michael D. DiCandilo, Senior Vice President & Chief Financial Officer
The dial-in number for the live call will be (612) 326-1011. No access code is required.
In order to ensure the widest distribution possible, the Company will be broadcasting the conference call over the Internet. The call will be accessible through the Investors page of AmerisourceBergen's web site, www.amerisourcebergen.com. Users are encouraged to log on to the webcast approximately 15 minutes in advance of the scheduled start time of the call.
Following the live call, replays will be made available on the Internet and via telephone. A replay of the webcast will be posted on www.amerisourcebergen.com approximately two hours after the completion of the call and will remain available for thirty days. To access the telephone replay from within the US, dial 800-475-6701. From outside the US, dial 320-365-3844. The access code is 746975. The telephone replay will be available from 2:30 p.m. EST on November 2, 2004 to 11:59 p.m. on November 9, 2004.
AmerisourceBergen (NYSE:ABC) is one of the largest pharmaceutical services companies in the United States. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation, bedside medication safety systems, and pharmaceutical packaging to pharmacy services for skilled nursing and assisted living facilities, reimbursement and pharmaceutical consulting services, and physician education. With more than $47 billion in annualized operating revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 14,000 people. AmerisourceBergen is ranked #22 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.
This news release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. Forward-looking statements may include statements addressing AmerisourceBergen's future financial and operating results.
The following factors, among others, could cause actual results to differ materially from those described in any forward-looking statements: competitive pressures; the loss of one or more key customer relationships; customer insolvencies; changes in customer mix; changes in pharmaceutical manufacturers' pricing and distribution policies or practices; regulatory changes; changes in U.S. government policies (including changes in government policies pertaining to drug reimbursement); changes in market interest rates; and other economic, business, competitive, regulatory and/or operational factors affecting the business of AmerisourceBergen generally.
More detailed information about these factors is set forth in AmerisourceBergen's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for fiscal 2003.
AmerisourceBergen is under no obligation to (and expressly disclaims any such obligation to) update or alter any forward looking statements whether as a result of new information, future events or otherwise.
CONTACT: AmerisourceBergen Corporation Michael N. Kilpatric, 610-727-7118 email@example.com SOURCE: AmerisourceBergen Corporation